Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

[1]  P. Biron,et al.  Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors. , 2001, The Journal of urology.

[2]  S. Fosså,et al.  A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma , 2000, British Journal of Cancer.

[3]  R. Motzer,et al.  Testicular germ-cell cancer. , 1997, The New England journal of medicine.

[4]  S. Fosså,et al.  Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Richard Sylvester,et al.  International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers , 1997 .

[6]  P. Wilkinson,et al.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Bokemeyer,et al.  A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  C. Bokemeyer,et al.  Single‐agent carboplatinum for advanced seminoma a phase II study , 1993, Cancer.

[9]  N. Geller,et al.  Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Bokemeyer,et al.  Single-Agent Carboplatinum for Advanced Seminoma , 1993 .

[11]  W. Wilmanns,et al.  Combination chemotherapy containing cisplatin/ifosfamide and vinblastine or etoposide in bulky seminoma , 1993 .

[12]  A. Horwich,et al.  The activity of single-agent carboplatin in advanced seminoma. , 1992, European journal of cancer.

[13]  L. Einhorn.  Treatment of testicular cancer: a new and improved model. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Ong,et al.  Alternatives to radiotherapy in the management of seminoma. , 1990, British journal of urology.

[15]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .